In Japan, two prescription medications are approved for male pattern hair loss, also known as androgenetic alopecia (AGA): finasteride and dutasteride.
Another option available in pharmacies, with guidance from a pharmacist, is topical minoxidil. Both oral medications require a doctor’s prescription following an examination.
The approvals come from Japan’s Ministry of Health, Labour and Welfare and the Pharmaceuticals and Medical Devices Agency (PMDA).
They confirm approved use in Japan, not a promise that every patient will respond the same way. Japan’s public health insurance does not cover these medicines for hair loss. Whether you live in Japan or are visiting, you pay the full clinic and pharmacy costs yourself.
Japan’s approved hair loss medicines at a glance
Japan’s drug regulations categorize medicines based on whether a doctor must prescribe them and whether a pharmacist must explain them.
The three approved options are divided into two groups: prescription medicines, which must be prescribed by a doctor, and pharmacy-class products, which are non-prescription medicines that require a pharmacist to explain their use before purchase.
Three approved options
| Medicine | Form | Japan status and approved use |
|---|---|---|
| Finasteride | Oral tablet | Prescription medicine approved in 2005 to slow male AGA progression |
| Dutasteride | Oral capsule | Prescription medicine approved in 2015 to treat male AGA |
| Topical minoxidil | Scalp product | Pharmacy-class product for men aged 20 and older, with pharmacist guidance |
The Japanese Dermatological Association’s 2017 guidelines strongly recommend finasteride, dutasteride, and topical minoxidil for men with androgenetic alopecia (AGA). However, they do not recommend oral minoxidil for this condition.
The approval wording in the table, slowing progression for finasteride and treating AGA for dutasteride, reflects how each medicine was studied, not which one is better.
How the medicines work and what to expect
Approved hair loss medications work in two ways: oral medications act on hormones, while topical minoxidil works directly on the scalp. Neither method provides instant results, and both require consistent use.
How finasteride and dutasteride work
Androgenic alopecia (AGA) occurs when hair follicles become sensitive to dihydrotestosterone (DHT). Finasteride inhibits one type of enzyme that converts testosterone into DHT, while dutasteride blocks both types of this enzyme.
Both medications lower DHT levels in the blood and scalp, helping to slow the shrinking of hair follicles and preserve existing hair.
How topical minoxidil works
Topical minoxidil was originally developed as a medication for high blood pressure. Physicians observed that one side effect was increased hair growth, which led to the creation of a scalp treatment.
The precise mechanism by which minoxidil works on hair follicles is not yet fully understood, but it seems to shorten the resting phase of hair growth and prolong the growth phase. Additionally, only a small amount of the drug is absorbed through the scalp.
When changes become visible
Some men begin to notice changes around 12 weeks, but a more meaningful evaluation typically occurs after 6 months. This timeline is based on Japanese product guidelines for finasteride, which suggest that initial benefits can be seen after about 3 months, with a full assessment of response after a 6-month trial.
If there is no improvement after this period, the doctor may decide to discontinue the medication and reevaluate the treatment plan.
In a randomized study of 1,553 men aged 18 to 41, men taking finasteride had 107 more hairs than men taking placebo after one year, counted in a 5.1 cm² circle of scalp about the size of a coin.2
A 24-week randomized trial found that dutasteride increased hair count and hair thickness more than finasteride or placebo over that period.3
When a hair loss medicine may not fit
An approved medication is not necessarily suitable for every individual. In Japan, the two oral medications are approved only for adult men with androgenetic alopecia (AGA). These medications can impact hormones, mood, and liver function tests. Understanding these limitations can help you determine what topics to discuss with your prescribing doctor.
Who should not take them
Finasteride and dutasteride are approved only for men with AGA. They are not approved for women, and safety in people under 20 has not been established. Pregnant women should not touch broken tablets or leaking capsules, because the medicine can be absorbed through the skin.
Topical minoxidil is also not for minors or for anyone who is pregnant or breastfeeding, has severe liver problems, or has heart, lung, or blood vessel disease.
Men planning a pregnancy with a partner should tell the doctor before starting. Dutasteride can reduce sperm count and movement, and the doctor can explain what that means for your plans before you start. Tell the doctor about any history of depression or liver problems as well.
Both oral medicines can lower PSA, the protein measured in prostate checks. In a 48-week study of men aged 40 to 60, finasteride reduced PSA by 40% to 50%.4 Tell any doctor who orders a PSA test that you are taking finasteride or dutasteride.
Side effects to know before starting
Side effects can involve sexual function and mood. A meta-analysis of 15 double-blind trials found these medicines raised the chance of sexual side effects about 1.57 times compared with placebo.5
Most side effects improve after discontinuing the medication. However, report any side effects early rather than waiting until they become severe. Contact your doctor if you notice any of the following:
- Changes in sexual desire, erection, or ejaculation that worry you
- Low mood that lasts or affects daily life
- Breast tenderness or swelling
- Yellowing of the eyes or skin, dark urine, or unusual fatigue
Questions to ask before starting treatment
Before you pay for treatment, agree on the follow-up plan. The doctor should explain how long to continue, when to return for checks, and what to do if side effects appear between visits, including after you leave Japan if you are visiting.
A focused consultation usually covers these questions:
- Which oral medicine fits my hair loss pattern better, finasteride or dutasteride?
- How long should I use it before we judge whether it is working?
- What side effects should prompt me to contact you between visits?
- Will you monitor my liver and PSA levels during treatment?
At our clinics in Tokyo and Yokohama, Japan, hair loss consultations start with an in-person scalp exam. The doctor can explain which approved medicine may fit your situation and discuss follow-up after you return home.
Frequently asked questions
- Which hair loss medicines are officially approved in Japan?
-
Japan has approved finasteride and dutasteride as prescription oral medicines for male pattern hair loss. Topical minoxidil is also available as a pharmacy-class product for men aged 20 and older.
Most men see a doctor first, because the oral medicines require a prescription and a scalp exam.
- Can I buy finasteride or dutasteride at a Japanese pharmacy without a prescription?
-
No. Both are prescription-only medicines in Japan. You need a doctor’s prescription after an examination. Topical minoxidil is different: adult men can buy a pharmacy-class version after the pharmacist explains how to use it on the scalp.
- Is oral minoxidil approved for hair loss in Japan?
-
No. Oral minoxidil is not approved in Japan as a hair loss treatment, and the Japanese dermatology guideline recommends against it. Use only the topical form, and never swallow the liquid.
- When should I see a doctor before starting a hair loss medicine?
-
See a doctor before you start an oral medicine, and again if your hair loss changes quickly, you notice sexual or mood side effects, or you have a planned prostate check.
The doctor can determine whether the loss is AGA and choose a medicine that fits your age, health history, and follow-up plans.
References
1. Manabe, M., Tsuboi, R., Itami, S., Osada, S. I., Amoh, Y., Ito, T., Inui, S., Ueki, R., Ohyama, M., Kurata, S., Kono, T., Saito, N., Sato, A., Shimomura, Y., Nakamura, M., Narusawa, H., Yamazaki, M., & Drafting Committee for the Guidelines for the Diagnosis and Treatment of Male- and Female-Pattern Hair Loss (2018). Guidelines for the diagnosis and treatment of male-pattern and female-pattern hair loss, 2017 version. The Journal of Dermatology, 45(9), 1031-1043. https://doi.org/10.1111/1346-8138.14470
2. Kaufman, K. D., Olsen, E. A., Whiting, D., Savin, R., DeVillez, R., Bergfeld, W., Price, V. H., Van Neste, D., Roberts, J. L., Hordinsky, M., Shapiro, J., Binkowitz, B., & Gormley, G. J. (1998). Finasteride in the treatment of men with androgenetic alopecia. Finasteride Male Pattern Hair Loss Study Group. Journal of the American Academy of Dermatology, 39(4 Pt 1), 578-89. https://doi.org/10.1016/s0190-9622(98)70007-6
3. Gubelin Harcha, W., Barboza Martínez, J., Tsai, T. F., Katsuoka, K., Kawashima, M., Tsuboi, R., Barnes, A., Ferron-Brady, G., & Chetty, D. (2014). A randomized, active- and placebo-controlled study of the efficacy and safety of different doses of dutasteride versus placebo and finasteride in the treatment of male subjects with androgenetic alopecia. Journal of the American Academy of Dermatology, 70(3), 489-498.e3. https://doi.org/10.1016/j.jaad.2013.10.049
4. D’Amico, A. V., & Roehrborn, C. G. (2007). Effect of 1 mg/day finasteride on concentrations of serum prostate-specific antigen in men with androgenic alopecia: a randomised controlled trial. The Lancet. Oncology, 8(1), 21-5. https://doi.org/10.1016/S1470-2045(06)70981-0
5. Lee, S., Lee, Y. B., Choe, S. J., & Lee, W. S. (2019). Adverse Sexual Effects of Treatment with Finasteride or Dutasteride for Male Androgenetic Alopecia: A Systematic Review and Meta-analysis. Acta Dermato-venereologica, 99(1), 12-17. https://doi.org/10.2340/00015555-3035





